Australian (ASX) Stock Market Forum

IMM - Immutep Limited

Jump to new
pixel said:
short-term resistance is strengthening at 4.3c.

For now, I'm off while the profit is there to take.
Click to expand...

That was probably not such a dumb idea: A profit is a profit is a profit :)

PRR n 22-09-14.gif

... waiting for the next support to show ...
 
Well after yesterdays announcement of strong results from clinical trials of its ovarian cancer CVac treatment, it was time (today) to push the benefits of getting on board whilst the iron is hot - well it has risen by 115% in the past couple of days. As the Motley Crew would say "why put it in a bank that is only giving you 1-2% interest when this type of stock can get you a 100%".

The treatment enables the vaccine to stimulate the patients own immune system to find and kill the cancer cells.
 
People need to refer to PRRs announcement (27th Feb 2015) whereby they state that the company has decided that CVAC is "considerably complex and costly" and made decision to "cease recruitment of CVAC". Granted they go on to say they will "seek to partner the future development of CVAC". It's hard to know how promising this is all up.
 
lucifuge said:
People need to refer to PRRs announcement (27th Feb 2015) whereby they state that the company has decided that CVAC is "considerably complex and costly" and made decision to "cease recruitment of CVAC". Granted they go on to say they will "seek to partner the future development of CVAC". It's hard to know how promising this is all up.
Click to expand...

...hang on, I'm just re-reading the 19th May announcement:

" hazard ratio of 0.17 95% CI of (0.02, 1.44, p-value=0.07)" It includes 1 !!!, it's not statistically significant at 5% level!! This is not evidence of improvement at the 5% level. My god.
 
According to today's announcements:
http://www.asx.com.au/asx/statistics/displayAnnouncement.do?display=pdf&idsId=01740410
http://www.asx.com.au/asx/statistics/displayAnnouncement.do?display=pdf&idsId=01740413
CVAC could finally gain traction - at least in the US

PRR 4yr w 13-05-16.png

Trading levels are still a far cry from May last year, but the Market appears to take notice.

PRR am 13-05-16.png

Still highly speculative, but I'm adding a few to my Bio-Health portfolio.
The gap may be closed yet; if it drops below that, I'm stopping out.
 
On December 1st, 2017, Prima Biomed Limited (PRR) changed its name and ASX code to Immutep Limited (IMM).
 
Biotechs confuse the hell out of me. Trying to decipher their clinical trial results can be a frustrating experience.

Is anyone else out there following Immutep? If so, can you please explain to me what has been the catalyst for its recent share price increase? I'm a little confused. :unsure:

big.chart-IMM.gif
 
On 3 September 2018 Immutep Limited announced that it will commence cell line development and the associated manufacturing steps for IMP761, an immunosuppressive agonist antibody to LAG-3. Since then, volume has increased dramatically and the share price has moved from 3.5c to close at 4.5c today.

As I mentioned in my last post in this thread, I don't really understand biotechs but there seems to be an air of confidence swirling around IMM at the moment. Worth a look perhaps for those who understand it a little better than I do.

big.chart-IMM.gif
 
greggles said:
Since then, volume has increased dramatically and the share price has moved from 3.5c to close at 4.5c today.
Click to expand...

Good looking chart …….

Market cap of around $140 million. Recent cap raise of about $6 million with cash on hand at 30th June of $23 million … They do burn a serious amount of cash per Quarter though.
 
Biotech company. Expecting some developments regarding LAG-3 related product candidates for immuno-oncology and auto-immune diseases this year.
 
IMM potential breakout alert! as came up on my scan alert this morning +11.11%! on big volume already...

IMM chart shows/indicates that 0.20c breakout alert happening as we speak so worth watching imo

DYOR as always .. Cheers tela
 
I had thought there had been discussion about this stock ?
I am getting it confused with something with a similar name or ticker?... what a shame!
Nice gap up, market likes the news obviously.

Screenshot_20201210-133339.png
 
frugal.rock said:
Nice gap up, market likes the news obviously.
Click to expand...

Yeah a couple of Biotechs on the move today ... This one closed up 60% and then the multi billion share Co GTG also up 42% o_O

Now given I own IBX (also up 8% today), I reckon its time for it to take a running spike given their human trials should be just about underway.

IMM will start their "New randomised, double-blind, placebo-controlled phase II clinical study" for Breast Cancer in Q1 CY2021 which is of interest to me because IBX is testing their low invasion/fast detection study also for Breast Cancer initially.

Sectors/Stocks often work in unison so maybe there might be more Bio's on the move. Got anyone interesting in your Bio cupboard Rock (@frugal.rock):bookworm:
 
frugal.rock said:
Am still holding GTG but have been for months.
I realised I have been getting Imugene (IMU) confused with this one...
Click to expand...

Good luck with GTG ... might be the turn around now??

Yeah, IMU also been doing well .... Market is a bit of a merry go round at the moment ... I'm currently out of tune with my last 3 picks being pretty crappy in what should be a winning market.

Time to sit out for a few days and re focus on what I've been doing wrong (even though I already know, lol):yuck:
 
Immutep (ASX: IMM) looks for understanding and development of immunotherapy drugs for cancer and autoimmune diseases.

IMM’s objective is to harness and strengthen the power of the body’s own immune systems through therapeutic intervention for the benefit of patients’ health. This is how immunotherapy fights cancer and autoimmune disease.

8 minute vid:
www.sharecafe.com.au

Immutep: fighting the good fight - ShareCafe

In this video, immunotherapy pioneer Immutep's (ASX: IMM) CEO Marc Voigt speaks with Share Cafe's Tim McGowen about the company's operations, clinical trials and future developments.
www.sharecafe.com.au www.sharecafe.com.au
 
that is a pretty big gap, for a company without any news ... probably get an ASX letter in the mail soon

1616725800759.png
 
Top